News

CRISPR/Cas9 press release
September 23, 2015

Diagenode’s CRISPR/Cas9 polyclonal antibody has been raised against the N-terminus of the Cas9 nuclease, extensively validated and optimized for excellent specificity and high yields in chromatin IP.

Tweets by Diagenode

活动

APHL 2024
Milwaukee, Wisconsin, USA
May 6-May 9, 2024
London Calling 2024
London, UK
May 21-May 24, 2024

查看所有活动

新闻

查看所有新闻

The European Regional Development Fund and Wallonia are investing in your future.

Extension of industrial buildings and new laboratories.

News

CRISPR/Cas9 press releaseSeptember 23, 2015

活动

新闻

CRISPR/Cas9 press release
September 23, 2015